학술논문

Clinical impact of a novel lipoprotein apheresis treatment on no‐option chronic limb‐threatening ischemia: Result from the REDUCTION VISCOSITY study.
Document Type
Article
Source
Therapeutic Apheresis & Dialysis; Oct2023, Vol. 27 Issue 5, p960-967, 8p
Subject
ISCHEMIA
BIOMARKERS
VISCOSITY
C-reactive protein
FIBRINOGEN
Language
ISSN
17449979
Abstract
Copyright of Therapeutic Apheresis & Dialysis is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)